BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9720446)

  • 1. [New trends in the treatment of arterial hypertension: identification of the I1 receptor and the pharmacology of imidazoline].
    Pavlović P
    Vojnosanit Pregl; 1998; 55(3):305-10. PubMed ID: 9720446
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective imidazoline receptor agonists for metabolic syndrome.
    Krentz AJ; Evans AJ
    Lancet; 1998 Jan; 351(9097):152-3. PubMed ID: 9449863
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology of moxonidine: an I1-imidazoline receptor agonist.
    Ernsberger P
    J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S27-41. PubMed ID: 11346217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective stimulation of I1-imidazoline receptors as a novel mechanism for antihypertensive action. Focus on moxonidine.
    Papp JG; Ollivier JP
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():v-vi. PubMed ID: 7533220
    [No Abstract]   [Full Text] [Related]  

  • 5. [Agonists of the imidazoline receptors].
    Ol'binskaia LI; Bochenkov IuV
    Eksp Klin Farmakol; 1999; 62(2):68-72. PubMed ID: 10340136
    [No Abstract]   [Full Text] [Related]  

  • 6. [The significance of the sympathetic nervous system during therapy for hypertension and related pathologies. Imidazoline-I1-receptor agonists. 17th Scientific Meeting of the International Society of Hypertension. Amsterdam, June 7, 1998].
    Dtsch Med Wochenschr; 1998 Aug; 123(33 Suppl):1-4. PubMed ID: 9739350
    [No Abstract]   [Full Text] [Related]  

  • 7. [Imidazoline receptor agonists in the practical treatment of hypertension].
    Ol'binskaia LI; Bochenkov IuV; Alekseeva IL
    Ter Arkh; 1998; 70(2):86-8. PubMed ID: 9551585
    [No Abstract]   [Full Text] [Related]  

  • 8. [Central nervous system as a target for the new antihypertensive agents].
    Nurminen ML
    Duodecim; 1999; 115(20):2267-73. PubMed ID: 11973931
    [No Abstract]   [Full Text] [Related]  

  • 9. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of imidazolines and imidazoline receptors role at the vascular level.
    Serban DN; Nechifor M; Slătineanu SM
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):37-44. PubMed ID: 12089957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I1 agents: a new approach to the treatment of hypertension.
    Dubar M; Pillion G
    Ann N Y Acad Sci; 1995 Jul; 763():642-58. PubMed ID: 7677384
    [No Abstract]   [Full Text] [Related]  

  • 13. The renaissance of centrally acting antihypertensive drugs.
    van Zwieten PA
    J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharma-clinics. Medication of the month. Moxonidine (Moxon)].
    Scheen AJ
    Rev Med Liege; 2000 Jan; 55(1):61-3. PubMed ID: 10803041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Imidazol receptor agonists--new possibilities for treating hypertension].
    Nowicki M; Wiecek A; Chudek J
    Postepy Hig Med Dosw; 1995; 49(5):631-43. PubMed ID: 8677226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Imidazole receptor agonists--a new advance in the treatment of hypertension?].
    Spinar J; Vítovec J
    Vnitr Lek; 2000 Feb; 46(2):122-5. PubMed ID: 11048538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacology of hypotensive drugs acting on central imidazoline receptors].
    Drzewoski J; Wiśniewska-Jarosińska M
    Pol Arch Med Wewn; 1998 Dec; 100(6):561-9. PubMed ID: 10405570
    [No Abstract]   [Full Text] [Related]  

  • 19. Moxonidine: a review.
    Morris ST; Reid JL
    J Hum Hypertens; 1997 Oct; 11(10):629-35. PubMed ID: 9400904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective imidazoline receptor agonists and lipid metabolism.
    Elisaf M; Tselepis A; Siamopoulos K
    Clin Chem Lab Med; 1999 Feb; 37(2):165. PubMed ID: 10219506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.